2548 results found
This report contains information on NHMRC administration and performance, and a record of our activities for the reporting period 2022–23. An accessible version of this document is available on the Transparency Portal.
It is an inspiring time for health and medical research in Australia as the National Health and Medical Research Council (NHMRC) sets the standard for achieving gender equity through its largest grant scheme, Investigator Grants.
Picato® is a prescription gel that treats skin actinic keratosis (potentially pre-cancerous sunspots). The journey to develop this product began in the 1970s when Queensland researcher, Jim Aylward, became interested in a local farming story about the healing properties of the sap of the radium weed Euphorbia peplus (E. peplus) when applied to sunspots on the skin.
MRFF – Preventive and Public Health Research Initiative – 2023 Optimising Screening, Diagnosis and Management of Obstructive Sleep Apnoea Grant Opportunity
NHMRC opened a Targeted Call for Research (TCR) into Frailty in Hospital Care: Complex Health Care on 31 October 2018 and closed on 30 January 2019. Due to an administrative issue at the close of minimum data which disadvantaged some applications, NHMRC elected to reopen this call in the interests of equity and fairness. The re-opened call closed on 21 March 2019.
NHMRC opened a Targeted Call for Research (TCR) into Per- and Poly-Fluoroalkylated Substances (PFAS) on 19 December 2018. Applications closed on 1 May 2019.
NHMRC opened a Targeted Call for Research (TCR) into Biotoxin-related illnesses on 21 July 2021. Applications closed on 15 September 2021.
10 of the Best research projects 2014 describes 10 Australian health and medical research projects chosen from among the thousands of NHMRC-funded medical research projects underway in Australia.
10 of the Best research projects 2013 showcases 10 Australian health and medical research projects chosen from among the thousands of NHMRC-funded medical research projects underway in Australia. These projects illustrate the extraordinary quality and diversity of work being undertaken with NHMRC support.
Until the 1970s, people experiencing infertility had few options. Commencing in the late 1960s, NHMRC-funded researchers at Monash University and other research centres in Melbourne began creating in vitro fertilisation (IVF) technologies and developed them into robust medical procedures that are now used worldwide. These technologies have significantly expanded the options available for those wishing to have a baby and today IVF is responsible for about 1 in 20 births in Australia.
The information described in the disclosure log table below has been released by NHMRC under the Freedom of Information Act 1982 and is available for public access.
The following tables provide answers to common questions regarding Microbial health-based targets. This information can be found in Chapter 5 of the Australian Drinking Water Guidelines (the Guidelines):
In 2022, working with its Health Research Impact Committee, National Health and Medical Research Council (NHMRC) developed the NHMRC Research Impact Position Statement.